
Facephi Biometria (FACE) | Financial Analysis & Statements
Facephi Biometria S.A. | Small-cap | Technology
Facephi Biometria S.A. | Small-cap | Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
49.7M
Total Liabilities
30.5M
Shareholders Equity
19.2M
Debt to Equity
1.59
Cash Flow Metrics
Revenue & Profitability Trend
Facephi Biometria Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 28.9M | 25.2M | 22.3M | 13.2M | 7.3M |
Cost of Goods Sold | 15.7M | 10.3M | 8.7M | -297.5K | 293.3K |
Gross Profit | 13.2M | 14.8M | 13.6M | 13.5M | 7.0M |
Gross Margin % | 45.7% | 59.0% | 60.9% | 102.3% | 96.0% |
Operating Expenses | |||||
Research & Development | - | 5.0K | 0 | 2.0K | - |
Selling, General & Administrative | 10.1M | 8.2M | 5.9M | 4.7M | 2.2M |
Other Operating Expenses | 965.3K | 1.6M | 1.1M | 623.6K | 551.1K |
Total Operating Expenses | 11.1M | 9.8M | 7.0M | 5.3M | 2.8M |
Operating Income | -6.0M | -4.1M | 2.6M | -412.1K | 120.9K |
Operating Margin % | -20.8% | -16.2% | 11.6% | -3.1% | 1.7% |
Non-Operating Items | |||||
Interest Income | 603.0K | 311.2K | 946 | 285 | 173.8K |
Interest Expense | 1.5M | 1.7M | 300.0K | 389.9K | 130.1K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -7.3M | -7.1M | 1.0M | -853.4K | -2.0M |
Income Tax | 1.6M | -2.7M | -81.0K | -299.5K | -147.2K |
Effective Tax Rate % | 0.0% | 0.0% | -7.9% | 0.0% | 0.0% |
Net Income | -8.9M | -4.3M | 1.1M | -553.9K | -1.9M |
Net Margin % | -30.8% | -17.1% | 5.0% | -4.2% | -25.5% |
Key Metrics | |||||
EBITDA | 201.3K | 970.2K | 4.8M | 1.1M | 578.4K |
EPS (Basic) | €-0.37 | €-0.20 | €0.06 | €-0.04 | €-0.13 |
EPS (Diluted) | €-0.37 | €-0.20 | €0.06 | €-0.04 | €-0.13 |
Basic Shares Outstanding | 24284709 | 21131174 | 17277624 | 15024193 | 14368390 |
Diluted Shares Outstanding | 24284709 | 21131174 | 17277624 | 15024193 | 14368390 |
Income Statement Trend
Facephi Biometria Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.5M | 2.4M | 1.9M | 1.3M | 6.0M |
Short-term Investments | 179.8K | 169.3K | 155.6K | 44.2K | 517.2K |
Accounts Receivable | 18.7M | 13.6M | 11.2M | 8.0M | 4.2M |
Inventory | - | - | - | - | - |
Other Current Assets | - | -1 | -1 | 1 | 1 |
Total Current Assets | 29.1M | 19.1M | 15.9M | 10.5M | 11.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 961.5K | 905.7K | 1.0M | 448.6K | 138.2K |
Goodwill | 11.8M | 11.8M | 7.6M | 5.1M | 4.1M |
Intangible Assets | 11.8M | 11.8M | 7.6M | 5.1M | 2.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | -2 | - | - | -1 | -1 |
Total Non-Current Assets | 20.6M | 26.6M | 16.4M | 7.9M | 4.9M |
Total Assets | 49.7M | 45.7M | 32.3M | 18.4M | 16.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 6.3M | 3.8M | 574.3K | 415.2K | 238.6K |
Short-term Debt | 9.3M | 8.7M | 4.0M | 1.2M | 983.7K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 27.0M | 22.4M | 12.8M | 4.5M | 2.8M |
Non-Current Liabilities | |||||
Long-term Debt | 920.4K | 3.0M | 3.8M | 5.0M | 6.1M |
Deferred Tax Liabilities | 694.7K | 209.9K | 64.1K | 42.5K | 68.4K |
Other Non-Current Liabilities | -3 | 3 | -1 | 1 | - |
Total Non-Current Liabilities | 3.5M | 3.3M | 4.3M | 5.2M | 6.1M |
Total Liabilities | 30.5M | 25.7M | 17.0M | 9.6M | 9.0M |
Equity | |||||
Common Stock | 1.0M | 851.6K | 697.3K | 605.4K | 577.1K |
Retained Earnings | -8.9M | -4.3M | 1.1M | -553.9K | -1.9M |
Treasury Stock | 341.6K | 394.0K | 454.1K | 556.5K | 341.8K |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 19.2M | 20.0M | 15.2M | 8.7M | 7.0M |
Key Metrics | |||||
Total Debt | 10.2M | 11.7M | 7.8M | 6.2M | 7.0M |
Working Capital | 2.1M | -3.3M | 3.1M | 6.0M | 8.3M |
Balance Sheet Composition
Facephi Biometria Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -7.3M | -7.1M | 1.0M | -853.4K | -2.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -2.1M | -5.0M | -9.3M | -5.3M | 3.1M |
Operating Cash Flow | -8.8M | -10.9M | -12.0M | -5.9M | 992.7K |
Investing Activities | |||||
Capital Expenditures | -243.6K | -1.5M | -1.5M | -303.3K | -163.3K |
Acquisitions | -8.0K | 0 | 0 | -188 | -157.6K |
Investment Purchases | - | 0 | -172.0K | -63.8K | -206.4K |
Investment Sales | 0 | 0 | 9.5K | 474.9K | - |
Investing Cash Flow | -277.4K | -1.5M | -1.7M | 107.6K | -533.8K |
Financing Activities | |||||
Share Repurchases | -380.5K | -450.7K | -338.1K | -585.9K | -1.8M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 0 | 5.2M | 1.6M | 0 | 7.0M |
Debt Repayment | -1.5M | -1.3M | -10.5K | -809.7K | -3.1M |
Financing Cash Flow | 7.6M | 9.5M | 8.6M | 1.3M | 6.6M |
Free Cash Flow | -4.5M | -9.0M | -7.9M | -6.2M | -861.0K |
Net Change in Cash | -1.5M | -2.9M | -5.1M | -4.5M | 7.1M |
Cash Flow Trend
Facephi Biometria Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
36.50
Forward P/E
-67.25
Price to Book
3.53
Price to Sales
2.07
PEG Ratio
-67.25
Profitability Ratios
Profit Margin
-26.55%
Operating Margin
-0.73%
Return on Equity
-45.19%
Return on Assets
-7.90%
Financial Health
Current Ratio
1.08
Debt to Equity
63.71
Beta
1.11
Per Share Data
EPS (TTM)
€-0.35
Book Value per Share
€0.76
Revenue per Share
€1.33
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
face | 69.3M | 36.50 | 3.53 | -45.19% | -26.55% | 63.71 |
Singular People | 149.5M | 28.20 | 3.07 | 11.74% | 4.98% | 39.24 |
Seresco S.A | 71.0M | 14.80 | 6.21 | 41.95% | 84.45% | 1.05 |
Soluciones | 44.0M | 41.25 | - | 9.79% | 30.64% | 0.75 |
Amadeus IT | 31.9B | 24.44 | 6.06 | 27.09% | 20.99% | 59.12 |
Indra Sistemas S.A | 6.0B | 15.87 | 4.17 | 29.07% | 7.44% | 55.27 |
Financial data is updated regularly. All figures are in the company's reporting currency.